NCT01452438View on ClinicalTrials.gov

Safety Surveillance of MenACWY-CRM Vaccine in Children

CompletedOBSERVATIONAL

Enrollment

393

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Meningococcal Disease

Interventions

BIOLOGICAL

MenACWY-CRM

MenACYW-CRM vaccination received as part of routine clinical care and as registered in the vaccine records.

Trial Locations (1)

91101

Kaiser Permanente South California, Pasadena

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY